Our novel observations suggest a selective loss of Stat5a protein during breast cancer progression, representing a newly defined mechanism to explain partially the observed frequent loss of Nuc-pYStat5a/b during breast cancer progression [29,30]. This evidence concerns the gene NUCB1 and breast carcinoma.